ReviewRenal failure2026
Overview of pseudo-acute kidney injury.
Review in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI), a common complication among hospitalized patients, is associated with significant morbidity and mortality. Pseudo-AKI, a condition in which serum creatinine levels meet AKI diagnostic criteria despite a preserved glomerular filtration rate, presents diagnostic challenges. It is frequently misdiagnosed or overlooked in clinical practice, potentially leading to unnecessary interventions or diagnostic delays. Pseudo-AKI is caused by the derangement in pathways of creatinine metabolism and handling, including increased creatinine production, reduced tubular creatinine secretion, sampling or assay interference, and urine extravasation. In this review, we provide an overview of the definition, epidemiology, pathophysiology, mechanisms, diagnosis, and management of pseudo-AKI, with the aim of raising important scientific questions that warrant further exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.